NEWS & RESOURCES
Memphis-based US Biologic is ready to take a vaccine to market that could help the fight against Lyme disease
US Biologic Presents Development of a Chewable Flu Vaccine: Offers New Tool to Increase Vaccine Equity, Avoid Needles, and Reduce Pandemics
The Lyme Disease Association, the Global Lyme Alliance, and US BIOLOGIC each contributed to educational materials to highlight the important role ecology plays in disease transmission. Feel free to use the materials for your educational needs.
In this video, US BIOLOGIC's leadership describe the challenges of zoonotic disease and Lyme disease how US BIOLOGIC addresses these challenges.